View this email in your browser.
October 5, 2022

In Case You Missed It

Report Your Results

If you test positive for COVID-19 outside of UC San Diego (including an at-home rapid antigen test), please report it by uploading a photo of your test results directly to your MyUCSDChart or MyStudentChart account. You will then receive a call. You should also report your positive test on your daily symptom and exposure screener and follow the guidance provided. If you have any additional questions or issues reporting, you can reach the Testing Support Line at 619-543-8260.  

Residential Masking No Longer Required

As part of Phase II, students are no longer required to wear face coverings in their own residential unit (apartments or suites). Testing is recommended on arrival and on day five after being away from campus. Masking currently remains required in all indoor classrooms and instructional settings, in clinical areas and on Triton/university transportation until further notice. Students should also continue to complete their daily symptom and exposure screening. Learn more on the Student Housing Safety page

Testing Lab Temporary Closure

UC San Diego’s EXCITE Lab will be closed on Sunday, Oct. 9, with normal operations resuming on Monday, Oct. 10. For those needing a quick turnaround on their test, please note that this temporary closure may result in a delay for any COVID-19 test samples submitted on Sunday.

Upcoming Town Halls

Faculty and Research Town Hall

Wednesday, Oct. 12 at 2:30 p.m.

Illustration of three researchers surrounded by symbols related to clinical trials, such as a microscope, test tube and hospital.

Help Combat New COVID-19 Variants

UC San Diego's AntiViral Research Center is now recruiting for the COVAIL Trial (also known as: COVID-19 VAriant Immunologic Landscape Trial), a Phase II study that is designed to evaluate the immune response and safety of updated vaccines intended to combat emerging COVID-19 variants like Omicron. The ultimate goal is to find the best way to protect people from emerging variants; participants will be compensated for their time. Those interested in participating in the study can register here. If you have any questions, please email covidvaccinesd@health.ucsd.edu.

Contribute to Monkeypox Vaccine Safety

UC San Diego is seeking clinical trial participants to study the safety and efficacy of various investigational Jynneos vaccine dosage strategies. The Jynneos vaccine was FDA-approved in 2019 for prevention of smallpox and monkeypox in adults and is currently being given to people at high risk for monkeypox. Those interested may register for the study here. You can also email monkeypoxresearch@health.ucsd.edu if you have any questions.

Your Questions Answered

Question: What is a bivalent vaccine?
Answer: Also referred to as an “updated booster,” the FDA-authorized Moderna COVID-19 Vaccine, Bivalent and Pfizer-BioNTech COVID-19 Vaccine, Bivalent boosters include:
  • An mRNA component of the original strain that provides an immune response that is broadly protective against COVID-19.
  • An mRNA component in common between the Omicron variant BA.4 and BA.5 lineages to provide better protection against COVID-19 caused by the Omicron variant.     
According to the FDA, the BA.4 and BA.5 lineages of the Omicron variant are currently causing most cases of COVID-19 in the U.S. and are predicted to circulate this fall and winter. In June, the agency’s Vaccines and Related Biological Products Advisory Committee voted overwhelmingly to include an omicron component in COVID-19 booster vaccines.
Question: Who can get an updated booster?
Answer: All eligible students, campus employees and health employees can receive the updated booster.
For the bivalent vaccine booster, you must have already received the original vaccination series with any approved vaccine, with or without any subsequent booster dosing. The bivalent vaccine booster should be received at least two months after completing the initial series.
Please note: To ensure the best immune response to the vaccine and to minimize side effects, it is recommended that persons who have recently contracted COVID-19 wait at least two months before getting the bivalent booster.
To learn more about eligibility, visit the Vaccination Availability webpage.
Question: How do I schedule a vaccination appointment?
Answer: Visit the UC San Diego Health COVID-19 Vaccine Scheduler webpage to schedule an appointment. 
If you have specific questions or would like to submit feedback about the Return to Learn program, please email rtl@ucsd.edu.
Subscribe to our email list.